First Manhattan Co. LLC. / TMO
First Manhattan Co. LLC.’s Thermo Fisher Scientific Inc Position
Does First Manhattan Co. LLC. own Thermo Fisher Scientific Inc (TMO)? Yes — 767.2K shares worth $377M (+1.05% of its 13F portfolio) as of Q1 2026, down from 768.9K shares the prior filed quarter.
Position Value
$377M
Q1 2026
Shares
767.2K
% of Portfolio
+1.05%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 767.2K | $377M | +1.05% |
| Q4 2025 | 768.9K | $446M | +1.17% |
| Q3 2025 | 775.2K | $376M | +0.99% |
| Q2 2025 | 956.7K | $388M | +1.10% |
| Q1 2025 | 948.6K | $472M | +1.38% |
| Q4 2024 | 891.3K | $464M | +1.36% |
| Q3 2024 | 886.3K | $549M | +1.63% |
| Q2 2024 | 905.6K | $501M | +1.61% |
| Q1 2024 | 913.5K | $531M | +1.72% |
| Q4 2023 | 917.8K | $485M | +1.68% |
| Q3 2023 | 1.02M | $515M | +1.90% |
| Q2 2023 | 961.7K | $500M | +1.83% |
| Q1 2023 | 724.8K | $418M | +1.60% |
| Q4 2022 | 652.1K | $359M | +1.32% |
| Q3 2022 | 639.0K | $323M | +1.37% |
| Q2 2022 | 643.5K | $348M | +1.40% |
| Q1 2022 | 630.6K | $372M | +1.22% |
| Q4 2021 | 635.1K | $424M | +1.40% |
| Q3 2021 | 637.9K | $364M | +1.34% |
| Q2 2021 | 635.1K | $320M | +1.17% |
| Q1 2021 | 544.8K | $249M | +1.07% |
| Q4 2020 | 542.8K | $253M | +1.21% |
| Q3 2020 | 552.7K | $244M | +1.26% |
| Q2 2020 | 538.9K | $195M | +1.13% |
| Q1 2020 | 556.3K | $158M | +1.02% |
| Q4 2019 | 561.0K | $182M | +0.91% |
| Q3 2019 | 568.0K | $165M | +0.91% |
| Q2 2019 | 568.2K | $167M | +0.93% |
| Q1 2019 | 507.4K | $139M | +0.80% |
| Q4 2018 | 489.2K | $109M | +0.68% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First Manhattan Co. LLC.’s full portfolio or all institutional holders of TMO.